The NIHR Clinical Research Network (CRN) has announced that it will shut down clinical trials in the country while the COVID-19 pandemic rages on. With more than 12,000 cases and over 500 deaths, the NIHR CRN announced it would “pause” all clinical trials to redeploy medical staff to the COVID-19 battle. The NIHR CRN is a research powerhouse supporting last year alone over 6,100 clinical trials while enrolling more than 870,000 study participants.
Focus on Frontlines of the Pandemic
This NIHR CRN pause will allow for the government agency to redirect focus, resources, and talent toward priority COVID-19 clinical research, enabling the clinical and epidemiological evidence to be gathered to help guide UK policy while supporting the pursuit of novel vaccines and treatments.
MHRA Continues to Operate
The Medicines and Healthcare products Regulatory Agency, the UKs regulatory body over drugs, diagnostics, and devices, shall continue to operate and offer approvals for studies with a priority model now in place.
About the NIHR
The National Institute for Health Research (NIHR) is a United Kingdom government agency which funds research into health and care. It is the lar...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).